Glycated collagen cross-linking alters cardiac mechanics in volume-overload hypertrophy.

Alteration of hemodynamic loading induces remodeling that includes changes in myocardial properties and extracellular matrix structure. We investigated the hypothesis that cardiac hypertrophy due to volume overload produces changes in myocardial diastolic mechanics and stiffness that are in part due to alterations in advanced glycation end-product (AGE) collagen cross-linking. Rats developed volume overload induced by arteriovenous fistula (AVF). To assess the dependence of AGE cross-linking on mechanics, we prevented AGE formation by administering the drug aminoguanidine (AG) to one group of AVF rats (AG+AVF). Volume overload did not modify collagen concentration. Right ventricular AGE cross-links were modestly elevated in AVF hearts but were significantly reduced by AG. AVF rats exhibited significantly increased septal AGE cross-links that were inhibited in the AG+AVF group. AVF-induced increases in left ventricular longitudinal stiffness and septal circumferential stiffness were prevented in AG+AVF hearts. Volume overload appears to regionally modify AGE collagen cross-linking and stiffness, and AG treatment prevented these increases, demonstrating that AGE cross-linking plays a role in mediating diastolic compliance in volume-overload hypertrophy.

[1]  R. Dunn.  Regional blood flow and metabolite levels in the left ventricular free wall and septum during aortic insufficiency: implications for the development of asymmetric septal hypertrophy. , 1986, Journal of the American College of Cardiology.

[2]  M. Huijberts,et al.  Breakers of advanced glycation end products restore large artery properties in experimental diabetes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Covell,et al.  Collagen characterization in volume-overload- and pressure-overload-induced cardiac hypertrophy in minipigs. , 1993, The American journal of physiology.

[4]  F. Plum.  Handbook of Physiology. , 1960 .

[5]  A. Cerami,et al.  An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[6]  G. Bianchi,et al.  Effect of propionyl-L-carnitine on the mechanics of right and left papillary muscles from volume-overloaded rat hearts. , 1996, Journal of cardiovascular pharmacology.

[7]  N. Simionescu,et al.  The Cardiovascular System , 1983 .

[8]  J W Covell,et al.  Dependence of ventricular distensibility on filling of the opposite ventricle. , 1967, The American journal of physiology.

[9]  C. Elmets,et al.  Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. , 1986, The New England journal of medicine.

[10]  S. Skinner.  Rapid method for the purification of the elastin cross-links, desmosine and isodesmosine. , 1982, Journal of chromatography.

[11]  K. Tracey,et al.  Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. , 1991, The Journal of clinical investigation.

[12]  T. Regan,et al.  Effects of Metformin on Collagen Glycation and Diastolic Dysfunction in Diabetic Myocardium , 1998, Journal of cardiovascular pharmacology and therapeutics.

[13]  G. Norton,et al.  Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats. , 1996, Circulation.

[14]  難波 隆志.  Regulation of fibrillar collagen gene expression and protein accumulation in volume-overloaded cardiac hypertrophy , 2002 .

[15]  M Duriez,et al.  Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Y. Obeng,et al.  Nuclear‐magnetic‐resonance characterization of doped SiO2 films used in integrated circuits , 1995 .

[17]  W. Sibbald,et al.  Right ventricular function in acute disease states: Pathophysiologic considerations , 1983, Critical care medicine.

[18]  F. Spinale,et al.  Cellular and extracellular remodeling with the development and recovery from tachycardia-induced cardiomyopathy: changes in fibrillar collagen, myocyte adhesion capacity and proteoglycans. , 1996, Journal of molecular and cellular cardiology.

[19]  H. Oxlund,et al.  Inhibition of cross-links in collagen is associated with reduced stiffness of the aorta in young rats. , 1998, Atherosclerosis.

[20]  J. F. Woessner,et al.  The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. , 1961, Archives of biochemistry and biophysics.

[21]  G. Norton,et al.  Exercise-induced cardiac hypertrophy is associated with an increased myocardial compliance. , 1995, Journal of applied physiology.

[22]  W Grossman,et al.  Cardiac hypertrophy: useful adaptation or pathologic process? , 1980, The American journal of medicine.

[23]  J. Covell,et al.  Increase in Cross‐Linking of Type I and Type III Collagens Associated With Volume‐Overload Hypertrophy , 1988, Circulation research.

[24]  A. Cerami,et al.  Protein glycation, diabetes, and aging. , 2001, Recent progress in hormone research.

[25]  D. Farrar,et al.  Pacing‐Induced Dilated Cardiomyopathy Increases Left‐to‐RightVentricular Systolic Interaction , 1993, Circulation.

[26]  M. Zile,et al.  Inhibition of collagen cross-linking: effects on fibrillar collagen and ventricular diastolic function. , 1995, The American journal of physiology.

[27]  R. Bucala,et al.  Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. Gibson,et al.  Relation of regional echo amplitude to left ventricular function and the electrocardiogram in left ventricular hypertrophy. , 1984, British heart journal.

[29]  A. Bailey,et al.  Non-enzymic glycation of fibrous collagen: reaction products of glucose and ribose. , 1995, The Biochemical journal.

[30]  G. Norton,et al.  Myocardial stiffness is attributed to alterations in cross-linked collagen rather than total collagen or phenotypes in spontaneously hypertensive rats. , 1997, Circulation.

[31]  J. Omens,et al.  Mechanical regulation of myocardial growth during volume-overload hypertrophy in the rat. , 1997, The American journal of physiology.

[32]  T. Regan,et al.  Effects of glucose intolerance on myocardial function and collagen-linked glycation. , 1999, Diabetes.

[33]  B. Nilsson.  Biological effects of aminoguanidine: An update , 1999, Inflammation Research.

[34]  A. McCulloch,et al.  Contribution of collagen matrix to passive left ventricular mechanics in isolated rat hearts. , 1994, The American journal of physiology.

[35]  A. Cerami,et al.  Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. , 1986, Science.

[36]  T. Koob,et al.  Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. , 1984, Analytical biochemistry.